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This meta-analysis broadly compared the safety and efﬁcacy of robot-assisted laparoscopy (RAL) with
that of conventional laparoscopy (CL) for endometrial cancer staging. The advantages of RAL were
evaluated through the outcomes in terms of conversion rates, complications, length of operation, blood
loss, number of lymph nodes harvested, and length of hospitalization. Three electronic databases
(PubMed, MEDLINE, and EmBASE) were searched to identify eligible studies. We selected all retro-
spective studies documenting a comparison between RAL and CL for endometrial cancer staging between
2005 and 2015, and tallied with meta-analyses criteria. Only studies published in English were included
in this analysis. The outcomes of the extracted data were pooled and estimated by the Review Manager
version 5.1 software. Seventeen studies met the eligibility criteria. Among the 2105 patients reported,
912 underwent RAL and the other 1193 underwent CL for endometrial cancer staging. Compared with CL,
RAL had lower conversion rates [risk ratio, 0.4; 95% conﬁdence interval (CI), 0.25e0.64; p ¼ 0.0002]. Its
complications were also less than that of CL (risk ratio, 0.72; 95% CI, 0.56e0.94; p ¼ 0.02). RAL was
associated with signiﬁcantly less intraoperative blood loss (weighted mean difference, 79.2 mL; 95% CI,
from 103.43 to 54.97; p < 0.00001) and a shorter length of hospitalization (weighted mean difference,
0.37 days; 95% CI, from 0.57 to0.17; p ¼ 0.0003). We found no signiﬁcant differences in the length of
operation and number of lymph nodes harvested between the two groups. From our meta-analysis re-
sults, RAL is a safe and effective alternative to CL for endometrial cancer staging. Further studies are
required to determine potential advantages or disadvantages of RAL.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Endometrial cancer is one of the most commonly seen gyne-
cologic malignancies, with a highly increasing incidence in the
developedworld [1]. The primary treatment for endometrial cancer
is total hysterectomy, bilateral salpingo-oophorectomy, and surgi-
cal staging [2]. Safe and effective surgery for endometrial cancer
serves as a linchpin for both disease prognosis and improved life
quality of the patients.
Over the past decade and a half, minimally invasive approaches
have increasingly been adopted by gynecologic oncologists for thes and Gynaecology, Women
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bstetrics & Gynecology. Publishedtreatment of endometrial cancer. Laparoscopic surgery is consid-
ered a preferred alternative to laparotomy because of less blood
loss and blood transfusion, shorter hospitalization, and better
cosmetic results [3,4]. However, theminimally invasive approach to
treat endometrial cancer has been limited owing to two dimen-
sioned visualization and strict requirement of skilled and experi-
enced surgeons. In recent years, the use of a robotic surgical
platform (Da Vinci Surgical System) has grown exponentially [5]. It
offers numerous potential beneﬁts, especially extensive suturing
and less collateral damage, in endometrial cancer staging.
All the beneﬁts of robot-assisted laparoscopic surgery (RAL)
surmounted the limits of conventional laparoscopic surgery (CL)
[6]. It was associated with a shorter hospital stay, a lower overall
complication rate, and fewer blood transfusions. In addition, it has
shortened the transition time of patients to normal social life and
improved their quality of life as well. However, studies comparing
RAL with CL in endometrial cancer staging are limited. The realby Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1. Flow diagram of studies identiﬁed in the meta-analysis.
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remained controversial.
The aim of this meta-analysis is to evaluate the efﬁcacy and
safety of RAL in endometrial cancer staging compared with CL.
Materials and methods
Search strategy
A systematic literature review was performed using electronic
databases (PubMed, MEDLINE, and EmBASE). All English-language
publications comparing RAL with CL for endometrial cancer stag-
ing from January 1, 2005 to April 25, 2015 have been identiﬁed. The
following key words were used in the search: [(robot* or “robotic
surgery” or “robotic staging”) and (“endometrial cancer” or
“endometrial carcinoma”)]. Moreover, the “related articles” offered
by databases were explored to broaden the search, and all abstracts,
studies, and citations were reviewed.
Finally, a manual search for relevant studies was also carried out
to identify studies for possible inclusion as a supplement.
Data extraction
The data were extracted by two researchers (Z.A. and H.R.)
independently for each eligible study comparing RAL and CL. Any
disagreements were resolved by a third reviewer (S.H.), until a
consensus was reached.
The quality of each study was evaluated using the New-
castleeOttawa Scale [7]. Seventeen studies were selected according
to the criteria based on the following three items: patient selection,
comparability of RAL and CL groups, and exposure. The quality of
study grades was evaluated based on an ordinal star scoring scale.
Higher scores represented higher quality of the study. One star for
each numbered item within the selection and exposure categories
in one study and a maximum of two stars for the comparability of
the two groups have been formulated. The studies with six or more
stars were considered to be of much higher quality.
Inclusion criteria
All the selected studies in the meta-analysis adhered to the
following inclusion criteria: (1) comparison of outcomes of RAL
with CL for endometrial cancer staging; (2) evaluation of length of
operation, blood loss, operative complications, and length of hos-
pital stay; (3) patient medical parameters (age, body mass index,
history of abdominal surgery, pre-existing complication conditions,
uterine weight, tumor stage, and tumor grade) in compared groups
not being statistically different; and (4) patients not having
received radiation therapy or chemotherapy preoperatively.
Exclusion criteria
The exclusion criteria for this meta-analysis were as follows: (1)
research articles, such as letters, editorials, and expert opinions; (2)
studies without original data, case reports, or studies lacking CL as a
control group; (3) studies not providing clear outcomes or patient
parameters; (4) studies including open hysterectomy or single-port
laparoscopic surgery alone; and (5) reports only on RAL surgeries.
Statistical analysis
This meta-analysis was performed using Revman 5.3 (Re-
view Manager version 5.3; The Nordic Cochrane Centre,
Copenhagen, Denmark) for the ﬁve primary outcome parame-
ters: length of operation, blood loss, conversion rates, numberof lymph nodes harvested, and length of hospitalization. The
statistical package of the software was applied to analyze the
risk ratios (RRs) for dichotomous variables and weighted mean
differences (WMDs) for continuous variables. Heterogeneity
was evaluated by F and I2. We considered heterogeneity to be
present if the I2 statistic was > 50%, and the threshold of sig-
niﬁcance was considered at p < 0.05. The publication bias was
evaluated by funnel plots.
Results
Study selection and study characteristics
The 17 studies [8e24] were selected from the search on RAL
surgery for endometrial cancer staging (Figure 1). All included
studies were retrospective and nonrandomized controlled com-
parison. The characteristics of these studies were summarized, and
the quality of studies was assessed. A total of 2105 patients were
identiﬁed: 912 in the RAL group and 1193 in the CL group. All
studies involved RAL versus CL for endometrial cancer staging. The
ﬁrst author and year of publication, patient parameters (age, body
mass index, tumor stage, tumor grade, and uterine weight), study
design, and the quality assessment of studies are given in Table 1.
Synthesis of results
Ten studies reported the rates of conversion. The pooled esti-
mate showed an RR of 0.4 (95% CI, 0.25e0.64) in favor of patients
who received RAL. The I2 was 0%, which suggested no heterogeneity
in pooled studies (see Figure 2). The reason for conversion in RAL
was exposure difﬁculty. However, other reasons, such as dense
adhesions, vascular injury, and obscuring anatomy, induced con-
version in CL to a greater extent.
Fourteen studies assessed the complications of the two surgical
procedures. It showed fewer complications in the RAL group than in
the CL group (RR, 0.72; 95% CI, 0.55e0.95; p ¼ 0.02; see Figure 3).
Even though a large number of studies reported fewer
Table 1
Descriptive data for each study.
Author Year Design Group Sample
size (n)
Age (y) BMI (kg/m2) Uterine
weight (g)
Tumor
stage
Basic state Matching Scores
Bell et al [8] 2008 RCS RAL 40 63.0 (10.1) 33.0 (8.5) 135.9 (72.8) NR 1, 2, 8 a, b, c, d, e, f *******
CL 30 68.4 (11.9) 31.9 (9.8) 138.5 (75.5) NR
Boggess et al [9] 2008 RCS RAL 103 61.9 (10.6) 32.9 (7.6) NR 89/3/10/1 1, 2, 3 a, b, c, d, e, f *******
CL 81 62 (10.8) 29.0 (6.5) NR 62/4/14/1
Magrina et al [10] 2008 RCS RAL 27 50.0 (15.6) 27.2 (5.9) NR 6/2/1/0 1, 2, 3, 4, 5, 6 a, b, c, d, e, f *******
CL 31 54.9 (14.3) 26.8 (4.6) NR 11/1/1/0
Gehrig et al [11] 2008 RCS RAL 49 63.7 (12) 39.5 (5.8) NR 0/44/0/5 1, 2, 3, 4, 8 a, b, c, d, e, f *******
CL 32 58.6 (12) 38.8 (6.3) NR 0/26/0/6
Veijovich et al [12] 2008 RCS RAL 25 59.5 (36e85) 27.6 (18.7e49.4) 106.5 (42e255) NR 1, 2 a, b, c, d, f ****
CL 4 54 (51e67) 24.6 (22e29) 76.3 (36e113) NR
Seamon et al [13] 2009 RCS RAL 105 59 (8.9) 34.2 (9) 132 (64) 87/3/10 1, 2, 3, 4, 6, 8 a, c, d, e, f ******
CL 76 57 (11) 28.7 (6.9) 133 (60) 86/5/9
CG et al [14] 2010 RCS RAL 102 62 (8.7) 32.32 (8.13) 148 (111) 82/3/16/1 1, 2, 3, 4, 5, 6, 7, 8 a, b, c, d, e, f *******
CL 173 59.6 (9.75) 32.7 (9.5) 139 (89.8) 152/9/11/
1
Holtz et al [15] 2010 RCS RAL 13 63.5 (11.3) 35.3 (10.7) 119 (54) 12/1/0/0 1, 2, 3, 4, 8 a, b, c, d, e, f *****
CL 20 63.3 (11.2) 27.8 (7.1) 109 (54) 17/2/1/0
Jung et al [16] 2010 RCS RAL 28 52.89 (11.91) 23.38 (3.08) 123.7 (61.25) 24/1/3/0 1, 2, 3, 5, 6, 7, 8 a, b, c, d, e, f *******
CL 25 49.88 (10.75) 25.17 (5.11) 118.1 (45.0) 20/4/1/0
Lim et al [17] 2010 RCS RAL 56 62.5 (8.4) 30.4 (8.8) NR NR 1, 2, 8 a, b, c, d, e, f ****
CL 56 61.4 (11.7) 28.2 (6.7) NR NR
Shah et al [18] 2011 RCS RAL 45 58.2 (7.57) 40.5 (11.0) 176.3 (45.5e905) NR 1, 2, 3 a, b, c, e, f ****
CL 118 69.9 (7.5) 29.8 (7.5) 134.4 (34e704) NR
Coronado et al [19] 2012 RCS RAL 71 63.7 (10.2) 28.7 (4.7) NR 57/4/9/1 1, 2, 3, 4, 5, 8 a, b, c, d, e, f *******
CL 84 65.9 (11.2) 27.2 (5.3) NR 72/4/6/2
Venkat et al [20] 2012 RCS RAL 27 58.2 (31e85) 33.5 (20e54) 138.9 (65e402) 19/0/6/1 1, 2, 3, 4, 8 a, b, c, d, h ******
CL 27 60.2 (42e92) 32.5 (19e61) 132.8 (31e222) 18/1/5/1
Escobar et al [21] 2012 RCS RAL 30 59.7 (60) 31.2 (32.0) NR 28/2/0/0 1, 2, 3, 4, 8 a, b, c, d, e, f *****
CL 30 60.9 (62.1) 28.7 (4.7) NR 57/4/9/1
Seror et al [22] 2014 RCS RAL 40 66.27 (63.4e69.2) 24.95 (23.6e26.3) NR 35/1/1/3 1, 2, 3, 6, 8 a, b, d, e, f *****
CL 106 66.91 (64.6e69.2) 25.35 (24.4e26.3) NR 76/10/18/
1
Turunen et al [23] 2013 RCS RAL 67 65.4 (8.5) 28.2 (5.7) NR NR 1, 2 a, b, c, d, f ****
CL 150 67.4 (10.6) 28.8 (5.9) NR NR
Chiou et al [24] 2015 RCS RAL 86 53.6 (11.1) 26.0 (5.2) NR 72/2/12/0 1, 2, 3, 5 a, b, c, d, f ******
CL 150 51.4 (14.2) 25.6 (5.6) NR 121/9/20/
0
RAL ¼ robot assisted laparoscopic group; CL ¼ conventional laparoscopic group; NR ¼ no reported; RCS ¼ retrospective comparative. Scores: *a ¼ length of operation;
b ¼ length of hospitalization; BMI ¼ body mass index; c ¼ blood loss; CL ¼ conventional laparoscopy; d ¼ number of lymph nodes harvested; df ¼ degrees of freedom;
e ¼ conversion rates; f ¼ complications; NR ¼ not reported; RAL ¼ robot-assisted laparoscopy; RCS ¼ retrospective comparative scores; 1 ¼ age; 2 ¼ tumor stage; 4 ¼ tumor
grade; 5 ¼ tumor type; 6 ¼ operation history; 7 ¼ medication history; 8 ¼ same surgeon or same group component.
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between the two groups. In the meta-analysis, the results favored
the patients of the RAL group.
Fourteen studies showed signiﬁcantly less blood loss in RAL
than in CL (WMD, e79.2 mL; 95% CI, from 103.43 to 54.97;
p < 0.00001; see Figure 4).Figure 2. Forest plot for conversion rates comparing RAL with CL. CI ¼ conﬁdence inter
laparoscopy.Sixteen studies examined the length of hospital stay in both RAL
and CL groups. The mean difference of 0.37 days (from 0.57
to 0.17; p ¼ 0.0003) shows that the patients in the RAL group
recovered more quickly with relatively high quality of life. The I2
was 87%, which indicated high statistical heterogeneity in the
studies (see Figure 5).val; CL ¼ conventional laparoscopy; df ¼ degrees of freedom; RAL ¼ robot-assisted
Figure 3. Forest plot for complications comparing RAL with CL. CI ¼ conﬁdence interval; CL ¼ conventional laparoscopy; df ¼ degrees of freedom; RAL ¼ robot-assisted laparoscopy.
S.-H. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 488e494 491With regard to the length of operation, all 17 studies indicated
no signiﬁcant difference between RAL and CL (WMD, 13.28 mi-
nutes; 95% CI, from 6.66 to 33.22; p ¼ 0.19; see Figure 6).
The total lymph nodes harvested were not clearly indicated in
ﬁve studies. Therefore, the results of the remaining 12 studies were
pooled. The analysis of pooled results showed no statistical sig-
niﬁcance (WMD, 0.86; 95% CI, from 2.24 to 3.96; p ¼ 0.59; see
Figure 7).
Publication bias
A funnel plot for studies comparing the conversion rates of
surgical technique was set up to access the publication bias. Effect
estimates with corresponding CIs showed that no study was
outside the limit of the 95% CI, which indicated a minimal publi-
cation bias in the literature review (see Figure 8). However, further
studies should be included so that the funnel plot could precisely
reﬂect the possible publication bias.Figure 4. Forest plot for blood loss comparing RAL with CL. CI ¼ conﬁdence interval; CL ¼Discussion
Surgical staging for endometrial cancer is considered the stan-
dard of care [8], which provides patients with a better chance for
cure. However, different surgical approaches could affect intra- and
postoperative outcomes and then directly inﬂuence the quality of
life of patients. RAL is a burgeoning technology that has improved
some of the inherent limitations of CL, such as two-dimensional
visualization and strict requirements for surgeons with skills and
experience. Our results in this meta-analysis showed that the ro-
botic surgical platform might offer outstanding advantages in
endometrial cancer staging. It could not only lower major compli-
cations, conversion rate, and blood loss, but also reduce hospital
stay. Nonetheless, there were signiﬁcant differences between RAL
and CL in terms of the length of operation and number of lymph
nodes harvested.
Most of the studies reported that perioperative outcomes of RAL
compared with CL embraced fewer operative complications, lowerconventional laparoscopy; df ¼ degrees of freedom; RAL ¼ robot-assisted laparoscopy.
Figure 5. Forest plot for the length of hospitalization comparing RAL with CL. CI ¼ conﬁdence interval; CL ¼ conventional laparoscopy; df ¼ degrees of freedom; RAL ¼ robot-
assisted laparoscopy; SD ¼ standard deviation.
Figure 6. Forest plot for the length of operation comparing RAL with CL. CI ¼ conﬁdence interval; CL ¼ conventional laparoscopy; df ¼ degrees of freedom; RAL ¼ robot-assisted
laparoscopy; SD ¼ standard deviation.
Figure 7. Forest plot for the number of lymph nodes harvested, comparing RAL with CL. CI ¼ conﬁdence interval; CL ¼ conventional laparoscopy; df ¼ degrees of freedom;
RAL ¼ robot-assisted laparoscopy.
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Figure 8. Funnel plot for assessing publication bias. RR ¼ risk ratio; SE ¼ standard
error.
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RAL might be attributed to the following factors: (1) the robotic
device allowed better detection of large and small vessels; (2)
improved hemostasis and clear identiﬁcation of small vessels
contributed to lower rates of blood transfusion in RAL; (3) RAL
might provide prominent advantages for endometrial cancer pa-
tients with obesity and other complex conditions, such as previous
abdominal surgery with severe adhesion, by lowering the conver-
sion rates [27e29]; and (4) robotic surgery has drastically
decreased the musculoskeletal fatigue over time in surgeons and
perhaps improves overall productivity and longevity of practice
[12].
In this meta-analysis, there were only slight differences in the
hospital stay between the two groups, but the majority of studies
were in favor of RAL. Robotic procedures allowed patients to
mobilize earlier and shorten their hospitalization [30].
Pelvic node dissection is suggested to have a therapeutic beneﬁt
for endometrial cancer staging in selected cases. Two studies re-
ported that the robotic instruments allowed better exposure and
reduced the technical challenges of surgical procedures [31,32]. RAL
offered easier and more comprehensive lymphadenectomy, which
surmounted the technical limitations of CL and improved the
staging surgery process for endometrial cancer. However, the
numbers of lymph nodes harvested were not statistically different
between the two groups in this meta-analysis.
Our analysis of the pooled data of 17 studies did not show sig-
niﬁcant differences in the length of operation between the RAL and
CL groups. Among the studies we examined, some [8,16,18] re-
ported the operative time to be prolonged but in a reasonable frame
in RAL. The difference in the length of operation could be attributed
to multiple variables: room setup time, time for draping and
docking the robot, and skin-to-skin procedure time. Meanwhile,
the learning curve for RAL was also a critical factor, which might
exert a confounding effect on this matter.
The length of operation, blood loss, length of stay, and lymph
nodes harvested showed signiﬁcant heterogeneity in the studies
we analyzed. This heterogeneity might be explained by the differ-
ences in many factors among surgeries reported in these studies,
such as surgeons' skills, surgical approaches, learning curves of the
robot operating system, and the extent of lymph node dissection.
The limitations of this meta-analysis should be taken into ac-
count while interpreting the results. First, most data were derived
from retrospective nonrandomized comparisons. Even though a
majority of surgical procedures were well designed, some short-
comings in their methodology still existed. Smaller sample size andlow level of clinical evidence might lead to a certain bias in the
study. Second, we still could not eliminate the differences in pa-
tients, as well as the skills and experience of surgeons, between the
two groups. It is well known that these factors affect the outcomes
of endometrial cancer staging. Third, this meta-analysis provided a
short-term outcome to expound the value of robotic assistance,
which might inﬂuence the comprehensive evaluation of the
measured markers. Based on that, further studies on long-term
outcomes should be performed, which will be helpful to ﬁnd po-
tential advantages and disadvantages of RAL.
In conclusion, this meta-analysis has shown more beneﬁts of
RAL for patients with endometrial cancer staging in comparison
with CL. However, multicenter, prospective, randomized controlled
studies should be performed to delineate the differences between
RAL and CL. These approaches can ultimately help determine
whether RAL is a safe and effective alternative to CL for endometrial
cancer staging surgery.Conﬂicts of interest
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